Pembrolizumab in relapsed or refractory Richter syndrome

被引：36

作者：

Armand, Philippe ^{[1
]}

Murawski, Niels ^{[2
]}

Molin, Daniel ^{[3
]}

Zain, Jasmine ^{[4
]}

Eichhorst, Barbara ^{[5
]}

Gulbas, Zafer ^{[6
]}

Hawkes, Eliza A. ^{[7
]}

Pagel, John M. ^{[8
]}

Phillips, Tycel ^{[9
]}

Ribrag, Vincent ^{[10
]}

Svoboda, Jakub ^{[11
]}

Stathis, Anastasios ^{[12
]}

Chatterjee, Arkendu ^{[13
]}

Orlowski, Robert ^{[13
]}

Marinello, Patricia ^{[13
]}

Christian, Beth ^{[14
,15
]}

机构：

[1] Dana Farber Canc Inst, Boston, MA 02115 USA

[2] Univ Klinikum Saarlandes Innere Med I, Homburg, Germany

[3] Uppsala Univ, Dept Immunol Genet & Pathol, Expt & Clin Oncol, Uppsala, Sweden

[4] City Hope Natl Med Ctr, Duarte, CA USA

[5] Univ Cologne, Cologne, Germany

[6] Anadolu Med Ctr, Istanbul, Turkey

[7] Austin Hlth, Olivia Newton John Canc Res Inst, Heidelberg, Vic, Australia

[8] Swedish Canc Inst, Swedish Ctr Blood Disorders & Stem Cell Transplan, Seattle, WA USA

[9] Rogel Canc Ctr, Ann Arbor, MI USA

[10] Inst Gustave Roussy, Villejuif, France

[11] Univ Penn, Perelman Ctr Adv Med, Philadelphia, PA 19104 USA

[12] Oncol Inst Southern Switzerland, Bellinzona, Switzerland

[13] Merck & Co Inc, Kenilworth, NJ USA

[14] Ohio State Univ, James Canc Hosp, Columbus, OH 43210 USA

[15] Ohio State Univ, Solove Res Inst, Columbus, OH 43210 USA

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2020年 / 190卷 / 02期

关键词：

chronic lymphocytic leukaemia; immunotherapy; PD-1; pembrolizumab; Richter syndrome; LYMPHOMA; TRANSFORMATION; OUTCOMES; CLL;

D O I：

10.1111/bjh.16762

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E117 / E120

页数：4

共 14 条

[1] Pembrolizumab in Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma
Armand, Philippe
Rodig, Scott
Melnichenko, Vladimir
Thieblemont, Catherine
Bouabdallah, Kamal
Tumyan, Gayane
Ozcan, Muhit
Portino, Sergio
Fogliatto, Laura
Caballero, Maria D.
Walewski, Jan
Gulbas, Zafer
Ribrag, Vincent
Christian, Beth
Perini, Guilherme Fleury
Salles, Gilles
Svoboda, Jakub
Zain, Jasmine
Patel, Sanjay
Chen, Pei-Hsuan
Ligon, Azra H.
Ouyang, Jing
Neuberg, Donna
Redd, Robert
Chatterjee, Arkendu
Balakumaran, Arun
Orlowski, Robert
Shipp, Margaret
Zinzani, Pier Luigi
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (34) : 3291 - +
[2] Pembrolizumab in relapsed or refractory Hodgkin lymphoma: 2-year follow-up of KEYNOTE-087
Chen, Robert
Zinzani, Pier Luigi
Lee, Hun Ju
Armand, Philippe
Johnson, Nathalie A.
Brice, Pauline
Radford, John
Ribrag, Vincent
Molin, Daniel
Vassilakopoulos, Theodoros P.
Tomita, Akihiro
von Tresckow, Bastian
Shipp, Margaret A.
Lin, Jianxin
Kim, Eunhee
Nahar, Akash
Balakumaran, Arun
Moskowitz, Craig H.
[J]. BLOOD, 2019, 134 (14) : 1144 - 1153
[3] Revised response criteria for malignant lymphoma
Cheson, Bruce D.
Pfistner, Beate
Juweid, Malik E.
Gascoyne, Randy D.
Specht, Lena
Horning, Sandra J.
Coiffier, Bertrand
Fisher, Richard I.
Hagenbeek, Anton
Zucca, Emanuele
Rosen, Steven T.
Stroobants, Sigrid
Lister, T. Andrew
Hoppe, Richard T.
Dreyling, Martin
Tobinai, Kensei
Vose, Julie M.
Connors, Joseph M.
Federico, Massimo
Diehl, Volker
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (05) : 579 - 586
[4] Autologous and Allogeneic Stem-Cell Transplantation for Transformed Chronic Lymphocytic Leukemia (Richter's Syndrome): A Retrospective Analysis From the Chronic Lymphocytic Leukemia Subcommittee of the Chronic Leukemia Working Party and Lymphoma Working Party of the European Group for Blood and Marrow Transplantation
Cwynarski, Kate
van Biezen, Anja
de Wreede, Liesbeth
Stilgenbauer, Stephan
Bunjes, Donald
Metzner, Bernd
Koza, Vladimir
Mohty, Mohamad
Remes, Kari
Russell, Nigel
Nagler, Arnon
Scholten, Marijke
de Witte, Theo
Sureda, Anna
Dreger, Peter
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (18) : 2211 - 2217
[5] Phase I First-in-Human Study of Venetoclax in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma
Davids, Matthew S.
Roberts, Andrew W.
Seymour, John F.
Pagel, John M.
Kahl, Brad S.
Wierda, William G.
Puvvada, Soham
Kipps, Thomas J.
Anderson, Mary Ann
Salem, Ahmed Hamed
Dunbar, Martin
Zhu, Ming
Peale, Franklin
Ross, Jeremy A.
Gressick, Lori
Desai, Monali
Kim, Su Young
Verdugo, Maria
Humerickhouse, Rod A.
Gordon, Gary B.
Gerecitano, John F.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (08) : 826 - 833
[6] Pembrolizumab in patients with CLL and Richter transformation or with relapsed CLL
Ding, Wei
LaPlant, Betsy R.
Call, Timothy G.
Parikh, Sameer A.
Leis, Jose F.
He, Rong
Shanafelt, Tait D.
Sinha, Sutapa
Le-Rademacher, Jennifer
Feldman, Andrew L.
Habermann, Thomas M.
Witzig, Thomas E.
Wiseman, Gregory A.
Lin, Yi
Asmus, Erik
Nowakowski, Grzegorz S.
Conte, Michael J.
Bowen, Deborah A.
Aitken, Casey N.
Van Dyke, Daniel L.
Greipp, Patricia T.
Liu, Xin
Wu, Xiaosheng
Zhang, Henan
Secreto, Charla R.
Tian, Shulan
Braggio, Esteban
Wellik, Linda E.
Micallef, Ivana
Viswanatha, David S.
Yan, Huihuang
Chanan-Khan, Asher A.
Kay, Neil E.
Dong, Haidong
Ansell, Stephen M.
[J]. BLOOD, 2017, 129 (26) : 3419 - 3427
[7] Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma
Green, Michael R.
Monti, Stefano
Rodig, Scott J.
Juszczynski, Przemyslaw
Currie, Treeve
O'Donnell, Evan
Chapuy, Bjoern
Takeyama, Kunihiko
Neuberg, Donna
Golub, Todd R.
Kutok, Jeffery L.
Shipp, Margaret A.
[J]. BLOOD, 2010, 116 (17) : 3268 - 3277
[8] HILLMEN P, 2016, BLOOD, V128
[9] Selective inhibition of nuclear export with selinexor in patients with non-Hodgkin lymphoma
Kuruvilla, John
Savona, Michael
Baz, Rachid
Mau-Sorensen, Paul Morten
Gabrail, Nashat
Garzon, Ramiro
Stone, Richard
Wang, Michael
Savoie, Lynn
Martin, Peter
Flinn, Ian
Jacoby, Meagan
Unger, Thaddeus J.
Saint-Martin, Jean-Richard
Rashal, Tami
Friedlander, Sharon
Carlson, Robert
Kauffman, Michael
Shacham, Sharon
Gutierrez, Martin
[J]. BLOOD, 2017, 129 (24) : 3175 - 3183
[10] Hodgkin transformation of chronic lymphocytic leukemia: Incidence, outcomes, and comparison to de novo Hodgkin lymphoma
Parikh, Sameer A.
Habermann, Thomas M.
Chaffee, Kari G.
Call, Timothy G.
Ding, Wei
Leis, Jose F.
Macon, William R.
Schwager, Susan M.
Ristow, Kay M.
Porrata, Luis F.
Kay, Neil E.
Slager, Susan L.
Shanafelt, Tait D.
[J]. AMERICAN JOURNAL OF HEMATOLOGY, 2015, 90 (04) : 334 - 338

← 1 2 →